B cell chronic lymphocytic leukemia (CLL) is the most common adult human leukemia. Despite this, the molecular alterations leading to CLL onset and progression are still under investigation, specifically, the interplay and exact role of oncogenes and tumor suppressors. miRNAs are small noncoding RNAs that regulate gene expression and are expressed in a tissue-specific manner. Deregulation of miRNAs can alter expression levels of genes involved in the development and/or progression of tumors. In CLL, miRNAs can function as oncogenes or tumor suppressors. Here, we review the most recent findings on the role of miRNAs in CLL and discuss how this knowledge can be used to identify new biomarkers and targets to treat this leukemia.
机构:
Univ Nebraska, Med Ctr, Dept Cellular & Integrat Physiol, Nebraska Med Ctr 985850, Omaha, NE 68198 USAUniv Nebraska, Med Ctr, Dept Cellular & Integrat Physiol, Nebraska Med Ctr 985850, Omaha, NE 68198 USA
机构:
Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiol, Nanjing, Peoples R ChinaNanjing Med Univ, Affiliated Hosp 1, Dept Cardiol, Nanjing, Peoples R China
Li, Peng
Sun, Haijian
论文数: 0引用数: 0
h-index: 0
机构:
Natl Univ Singapore, Dept Pharmacol, Singapore, SingaporeNanjing Med Univ, Affiliated Hosp 1, Dept Cardiol, Nanjing, Peoples R China
Sun, Haijian
Tang, Haiyang
论文数: 0引用数: 0
h-index: 0
机构:
Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Hlth,State Key Lab Resp Dis, Natl Clin Res Ctr Resp Dis,Guangdong Key Lab Vasc, Guangzhou, Peoples R ChinaNanjing Med Univ, Affiliated Hosp 1, Dept Cardiol, Nanjing, Peoples R China